USANA Health Sciences, Inc. (USNA) Stock Overview
Explore USANA Health Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
USANA Health Sciences, Inc. (USNA)
Key Financials
Key Financials
Market Cap
244.4M
P/E Ratio
-10.66
EPS (TTM)
$0.99
ROE
-0.04%
USNA Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of USANA Health Sciences, Inc. (NYSE: USNA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, USANA Health Sciences, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of USNA on the NYSE shows an RSI of 23.95, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $9.37 for the NYSE listing.
Key metrics behind USANA Health Sciences, Inc.'s NYSE-traded stock include a P/E ratio of -10.66 and a market capitalization of 244.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of USNA on the NYSE.